MedPath
NMPA Approval

Dacomitinib Tablets

国药准字H20234140

December 18, 2023

Drug Information

达可替尼片

片剂

45mg

化学药品

December 18, 2023

Company Information

Applicant Company

成都高新区和祥三街263号

Manufacturing Company

成都市双流西南航空港经济开发区空港四路1166号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

达可替尼片 - NMPA 批准文号 | MedPath